Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo

Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo

Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy <i>in vivo</i>, Published online: 13 August 2018; doi:10.1038/nbt.4195

Anti-PD-1 secreted by CAR-T cells remains localized to the tumor and improves therapeutic outcome in mice.

***

Note from Journals.Today : This content has been auto-generated from a syndicated feed.